GFACX
Price
$75.28
Change
+$0.05 (+0.07%)
Updated
Sep 16 closing price
Net Assets
340.23B
RGEBX
Price
$84.51
Change
+$0.06 (+0.07%)
Updated
Sep 16 closing price
Net Assets
340.23B
Interact to see
Advertisement

GFACX vs RGEBX

Header iconGFACX vs RGEBX Comparison
Open Charts GFACX vs RGEBXBanner chart's image
American Funds Growth Fund of Amer C
Price$75.28
Change+$0.05 (+0.07%)
VolumeN/A
Net Assets340.23B
American Funds Growth Fund of Amer R2E
Price$84.51
Change+$0.06 (+0.07%)
VolumeN/A
Net Assets340.23B
GFACX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. RGEBX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX (340B) and RGEBX (340B) have equal amount of cash in the bank . GFACX (0.00) and RGEBX (0.00) have matching dividends . GFACX was incepted earlier than RGEBX: GFACX (25 years) vs RGEBX (11 years). GFACX (1.36) is less costly to investors than RGEBX (1.09). GFACX (25.00) and RGEBX (25.00) have comparable annual turnover. GFACX (250) and RGEBX (250) have matching initial minimum investment requirements. RGEBX annual gain was more profitable for investors over the last year : 16.73 vs. GFACX (15.28). RGEBX return over 5 years is better than : 44.82 vs. GFACX (38.56).
GFACXRGEBXGFACX / RGEBX
Total Expense Ratio1.361.09125%
Annual Report Gross Expense Ratio1.361.09125%
Fund Existence25 years11 years-
Gain YTD18.06818.29599%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets340B340B100%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.2816.7391%
Returns for 3 years56.1860.7193%
Returns for 5 years38.5644.8286%
Returns for 10 years84.3796.2988%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHLR2.300.40
+21.05%
Wheeler Real Estate Investment Trust Inc
WHWK1.950.09
+4.84%
Whitehawk Therapeutics Inc
MANH214.272.81
+1.33%
Manhattan Associates
WLYB41.10N/A
N/A
John Wiley & Sons
ZKH2.94N/A
-0.17%
ZKH Group Limited